Go Pro

MarketBeat Instant News Alerts

Arch Capital Group logo with Finance background

JPMorgan Chase & Co. Issues Positive Forecast for Arch Capital Group (NASDAQ:ACGL) Stock Price

JPMorgan Chase & Co. raised their price target on shares of Arch Capital Group from $116.00 to $118.00 and gave the stock a "neutral" rating in a report on Tuesday.

NASDAQ:ACGL
Read JPMorgan Chase & Co. Issues Positive Forecast for Arch Capital Group (NASDAQ:ACGL) Stock Price
GCM Grosvenor logo with Finance background

GCM Grosvenor (NASDAQ:GCMG) Price Target Raised to $13.00 at JPMorgan Chase & Co.

JPMorgan Chase & Co. raised their price target on shares of GCM Grosvenor from $12.00 to $13.00 and gave the company a "neutral" rating in a report on Tuesday.

NASDAQ:GCMG
Read GCM Grosvenor (NASDAQ:GCMG) Price Target Raised to $13.00 at JPMorgan Chase & Co.
MercadoLibre logo with Consumer Discretionary background

JPMorgan Chase & Co. Increases MercadoLibre (NASDAQ:MELI) Price Target to $2,150.00

JPMorgan Chase & Co. increased their target price on MercadoLibre from $1,900.00 to $2,150.00 and gave the company a "neutral" rating in a research report on Tuesday.

NASDAQ:MELI
Read JPMorgan Chase & Co. Increases MercadoLibre (NASDAQ:MELI) Price Target to $2,150.00
MetLife logo with Finance background

MetLife (NYSE:MET) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

JPMorgan Chase & Co. raised their price target on shares of MetLife from $106.00 to $108.00 and gave the stock an "overweight" rating in a research note on Tuesday.

NYSE:MET
Read MetLife (NYSE:MET) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Rapid7 logo with Technology background

Rapid7 (NASDAQ:RPD) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

JPMorgan Chase & Co. upped their price objective on Rapid7 from $7.00 to $12.00 and gave the stock a "neutral" rating in a research report on Tuesday.

NASDAQ:RPD
Read Rapid7 (NASDAQ:RPD) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Oruka Therapeutics logo with Healthcare background

Oruka Therapeutics' (ORKA) "Buy" Rating Reaffirmed at Guggenheim

Guggenheim restated a "buy" rating and set a $200.00 price objective on shares of Oruka Therapeutics in a research note on Tuesday.

NASDAQ:ORKA
Read Oruka Therapeutics' (ORKA) "Buy" Rating Reaffirmed at Guggenheim

Trending News

All MarketBeat Instant News Alerts

Reinsurance Group of America logo with Finance background

Reinsurance Group of America (NYSE:RGA) Given New $293.00 Price Target at JPMorgan Chase & Co.

NYSE:RGA
Read Reinsurance Group of America (NYSE:RGA) Given New $293.00 Price Target at JPMorgan Chase & Co.
United Parks & Resorts logo with Consumer Discretionary background

United Parks & Resorts (NYSE:PRKS) Given New $44.00 Price Target at JPMorgan Chase & Co.

NYSE:PRKS
Read United Parks & Resorts (NYSE:PRKS) Given New $44.00 Price Target at JPMorgan Chase & Co.
Voya Financial logo with Finance background

JPMorgan Chase & Co. Raises Voya Financial (NYSE:VOYA) Price Target to $109.00

NYSE:VOYA
Read JPMorgan Chase & Co. Raises Voya Financial (NYSE:VOYA) Price Target to $109.00
Aflac logo with Finance background

JPMorgan Chase & Co. Has Lowered Expectations for Aflac (NYSE:AFL) Stock Price

NYSE:AFL
Read JPMorgan Chase & Co. Has Lowered Expectations for Aflac (NYSE:AFL) Stock Price
Qfin logo with Finance background

Qfin (NASDAQ:QFIN) Given New $13.50 Price Target at JPMorgan Chase & Co.

NASDAQ:QFIN
Read Qfin (NASDAQ:QFIN) Given New $13.50 Price Target at JPMorgan Chase & Co.
Legend Biotech logo with Healthcare background

Legend Biotech (NASDAQ:LEGN) Announces Earnings Results

NASDAQ:LEGN
Read Legend Biotech (NASDAQ:LEGN) Announces Earnings Results
Microbot Medical logo with Healthcare background

Microbot Medical (NASDAQ:MBOT) Issues Earnings Results

NASDAQ:MBOT
Read Microbot Medical (NASDAQ:MBOT) Issues Earnings Results
Vor Biopharma logo with Healthcare background

Vor Biopharma (NASDAQ:VOR) Posts Earnings Results

NASDAQ:VOR
Read Vor Biopharma (NASDAQ:VOR) Posts Earnings Results
Summit Midstream Partners logo with Energy background

Summit Midstream Partners (NYSE:SMC) Trading Up 6.1% Following Earnings Beat

NYSE:SMC
Read Summit Midstream Partners (NYSE:SMC) Trading Up 6.1% Following Earnings Beat
VSE logo with Industrials background

VSE (NASDAQ:VSEC) Trading 6.4% Higher Following Analyst Upgrade

NASDAQ:VSEC
Read VSE (NASDAQ:VSEC) Trading 6.4% Higher Following Analyst Upgrade
Transcat logo with Industrials background

Transcat (NASDAQ:TRNS) Trading Up 7.7% on Insider Buying Activity

NASDAQ:TRNS
Read Transcat (NASDAQ:TRNS) Trading Up 7.7% on Insider Buying Activity
Corpay logo with Finance background

Corpay (NYSE:CPAY) Reaches New 12-Month High on Analyst Upgrade

NYSE:CPAY
Read Corpay (NYSE:CPAY) Reaches New 12-Month High on Analyst Upgrade
Marathon Petroleum logo with Energy background

Marathon Petroleum (NYSE:MPC) Reaches New 52-Week High After Analyst Upgrade

NYSE:MPC
Read Marathon Petroleum (NYSE:MPC) Reaches New 52-Week High After Analyst Upgrade
Bicara Therapeutics logo with Healthcare background

Bicara Therapeutics (NASDAQ:BCAX) Posts Earnings Results, Hits Expectations

NASDAQ:BCAX
Read Bicara Therapeutics (NASDAQ:BCAX) Posts Earnings Results, Hits Expectations
Autolus Therapeutics logo with Healthcare background

Autolus Therapeutics (NASDAQ:AUTL) Releases Earnings Results, Beats Estimates By $0.06 EPS

NASDAQ:AUTL
Read Autolus Therapeutics (NASDAQ:AUTL) Releases Earnings Results, Beats Estimates By $0.06 EPS
Aura Biosciences logo with Healthcare background

Aura Biosciences (NASDAQ:AURA) Posts Quarterly Earnings Results, Misses Expectations By $0.10 EPS

NASDAQ:AURA
Read Aura Biosciences (NASDAQ:AURA) Posts Quarterly Earnings Results, Misses Expectations By $0.10 EPS
Clover Health Investments logo with Healthcare background

Clover Health Investments (NASDAQ:CLOV) Shares Down 4.7% After Insider Selling

NASDAQ:CLOV
Read Clover Health Investments (NASDAQ:CLOV) Shares Down 4.7% After Insider Selling
Neurogene logo with Healthcare background

Neurogene (NASDAQ:NGNE) Stock Price Down 7.8% on Disappointing Earnings

NASDAQ:NGNE
Read Neurogene (NASDAQ:NGNE) Stock Price Down 7.8% on Disappointing Earnings
Red Violet logo with Industrials background

Red Violet (NASDAQ:RDVT) Shares Up 6.3% on Earnings Beat

NASDAQ:RDVT
Read Red Violet (NASDAQ:RDVT) Shares Up 6.3% on Earnings Beat
Consolidated Water logo with Utilities background

Consolidated Water (NASDAQ:CWCO) Stock Price Up 7.5% Following Strong Earnings

NASDAQ:CWCO
Read Consolidated Water (NASDAQ:CWCO) Stock Price Up 7.5% Following Strong Earnings
Chipmos Technologies logo with Technology background

Chipmos Technologies (NASDAQ:IMOS) Stock Price Up 8.3% After Strong Earnings

NASDAQ:IMOS
Read Chipmos Technologies (NASDAQ:IMOS) Stock Price Up 8.3% After Strong Earnings
Septerna logo with Healthcare background

Septerna (NASDAQ:SEPN) Stock Price Up 9% Following Earnings Beat

NASDAQ:SEPN
Read Septerna (NASDAQ:SEPN) Stock Price Up 9% Following Earnings Beat
AdaptHealth logo with Healthcare background

AdaptHealth (NASDAQ:AHCO) Trading Up 10.5% on Insider Buying Activity

NASDAQ:AHCO
Read AdaptHealth (NASDAQ:AHCO) Trading Up 10.5% on Insider Buying Activity
Autolus Therapeutics logo with Healthcare background

Autolus Therapeutics (NASDAQ:AUTL) Trading 13.3% Higher Following Strong Earnings

NASDAQ:AUTL
Read Autolus Therapeutics (NASDAQ:AUTL) Trading 13.3% Higher Following Strong Earnings

Featured Articles and Offers

Alert Categories

All Alerts